Indications -- Sepsis/Acute Inflammation

Sponsor

Biotech / Medical: Indications -- Sepsis/Acute Inflammation

Posts: 79 | Member SubjectMarks: 18 | No Bans

Moderated By: scaram(o)uche -- (Not Moderated) -- Started: 9/17/2001 8:12:34 AM Revision History

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Date
79	Biochem Biophys Res Commun. 2013 Apr 10. pii: S0006-291X(13)00602-5. doi: 10.101	scaram(o)uche	-	04/17/2013 09:54 AM
78	Am J Surg. 2013 Jan 30. pii: S0002-9610(13)00023-8. doi: 10.1016/j.amjsurg.2012.	scaram(o)uche	-	02/06/2013 06:52 PM
77	London, UK, 8 August 2012: BTG plc (LSE: BTG), announces top-line data from a gl	nigel bates	-	08/08/2012 04:01 AM
76	"While there were no new safety findings, the study failed to demonstrate t	scaram(o)uche	-	10/25/2011 09:10 AM
75	J Pharmacol Exp Ther. 2011 Jun 14. [Epub ahead of print] Targeting cannabinoid	scaram(o)uche	-	06/17/2011 01:01 PM
74	Br J Pharmacol. 2011 Mar 30. [Epub ahead of print] A new cannabinoid 2 receptor	scaram(o)uche	-	04/19/2011 05:51 PM
73	J Physiol. 2011 Mar 14. [Epub ahead of print] The hypothermic response to bacte	scaram(o)uche	-	04/17/2011 03:13 PM
72	NVS Reports Positive Phase-3 Data for 4CMenB in Infants: investorshub.advfn.com	DewDiligence_on_SI	-	09/12/2010 05:46 PM
71	Immunology. 2010 Apr 6. [Epub ahead of print] Seladin-1 is a novel lipopolysacc	scaram(o)uche	-	04/22/2010 03:09 PM
70	Protection from lethal Gram-negative bacterial sepsis by targeting Toll-like rec	tnsaf	-	02/09/2009 01:35 PM
69	Contact: Emily Shafer emily.shafer@jefferson.edu 215-955-5291 Jefferson scienti	idos	-	01/23/2009 02:40 AM

Go to reply# or date (mm/dd/yy):